DK0636173T3 - Behandling af HIV associeret immunthrombocytopenisk purpura - Google Patents

Behandling af HIV associeret immunthrombocytopenisk purpura

Info

Publication number
DK0636173T3
DK0636173T3 DK92912556T DK92912556T DK0636173T3 DK 0636173 T3 DK0636173 T3 DK 0636173T3 DK 92912556 T DK92912556 T DK 92912556T DK 92912556 T DK92912556 T DK 92912556T DK 0636173 T3 DK0636173 T3 DK 0636173T3
Authority
DK
Denmark
Prior art keywords
hiv
treatment
thrombocytopenic purpura
immune thrombocytopenic
associated immune
Prior art date
Application number
DK92912556T
Other languages
English (en)
Inventor
Arthur J Ammann
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0636173T3 publication Critical patent/DK0636173T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92912556T 1991-05-31 1992-04-15 Behandling af HIV associeret immunthrombocytopenisk purpura DK0636173T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70900691A 1991-05-31 1991-05-31
PCT/US1992/003138 WO1992021755A1 (en) 1991-05-31 1992-04-15 Treatment of hiv-associated immune thrombocytopenic purpura

Publications (1)

Publication Number Publication Date
DK0636173T3 true DK0636173T3 (da) 1999-05-31

Family

ID=24848090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912556T DK0636173T3 (da) 1991-05-31 1992-04-15 Behandling af HIV associeret immunthrombocytopenisk purpura

Country Status (9)

Country Link
US (1) US5605689A (da)
EP (1) EP0636173B1 (da)
JP (1) JPH06508133A (da)
AT (1) ATE170559T1 (da)
AU (1) AU651228B2 (da)
CA (1) CA2108580A1 (da)
DE (1) DE69226877T2 (da)
DK (1) DK0636173T3 (da)
WO (1) WO1992021755A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
CN1911965B (zh) * 2001-01-17 2013-05-29 新兴产品开发西雅图有限公司 结合域-免疫球蛋白融合蛋白
AU2008200400B2 (en) * 2001-01-17 2012-06-07 Aptevo Research And Development Llc Binding domain-immunoglobulin fusion proteins
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
AU2002363465A1 (en) * 2001-10-25 2003-05-19 The Government Of The United States Of America As Represented By The Secretary Of Health And Human S Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
US6707888B1 (en) * 2002-05-06 2004-03-16 Sprint Communications Company, L.P. Location evaluation for callers that place emergency telephone calls over packet networks
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
DE602004031390D1 (de) * 2003-05-06 2011-03-24 Syntonix Pharmaceuticals Inc Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten
US7348004B2 (en) * 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
US7754209B2 (en) 2003-07-26 2010-07-13 Trubion Pharmaceuticals Binding constructs and methods for use thereof
UA97469C2 (uk) 2005-07-25 2012-02-27 Емерджент Продакт Дівелопмент Сіетл, Елелсі Гуманізована специфічна до cd37 зв'язувальна молекула імуноглобуліну
BRPI0616323A2 (pt) 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
NZ573646A (en) 2006-06-12 2012-04-27 Wyeth Llc Single-chain multivalent binding proteins with effector function
EP3248474A1 (en) * 2006-11-29 2017-11-29 Prolacta Bioscience, Inc. Human milk compositions
JP5616066B2 (ja) 2006-12-08 2014-10-29 プロラクタ バイオサイエンス，インコーポレイテッド ヒト脂質組成物ならびにその製造および使用方法
NZ603059A (en) 2008-04-11 2014-07-25 Emergent Product Dev Seattle Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
JP6062433B2 (ja) 2011-08-03 2017-01-18 プロラクタ バイオサイエンス，インコーポレイテッド 細菌汚染を低減するためのヒト乳の精密濾過
WO2014158911A1 (en) 2013-03-13 2014-10-02 Prolacta Bioscience High fat human milk products
EP2968498A4 (en) 2013-03-15 2016-09-07 Biogen Ma Inc PREPARATIONS CONTAINING FACTOR IX POLYPEPTIDE
US11352426B2 (en) 2015-09-21 2022-06-07 Aptevo Research And Development Llc CD3 binding polypeptides
AU2016381834B2 (en) 2015-12-30 2021-09-23 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao
ZA89430B (en) * 1988-01-22 1989-10-25 Gen Hospital Corp Cloned genes encoding ig-cd4 fusion proteins and the use thereof
ATE137801T1 (de) * 1988-07-06 1996-05-15 Verigen Inc A Corp Of Delaware Gegen hiv 1 gp48 spezifische antikörper
IL91386A0 (en) * 1988-08-24 1990-04-29 Boehringer Ingelheim Kg Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it
ATE108335T1 (de) * 1989-03-03 1994-07-15 Microgenesys Inc Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
JPH04506513A (ja) * 1989-04-03 1992-11-12 ジェネティックス・インスティテュート・インコーポレイテッド 巨核球増殖促進活性
EP0394827A1 (en) * 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimaeric CD4-immunoglobulin polypeptides

Also Published As

Publication number Publication date
JPH06508133A (ja) 1994-09-14
AU2003192A (en) 1993-01-08
DE69226877T2 (de) 1999-03-11
ATE170559T1 (de) 1998-09-15
US5605689A (en) 1997-02-25
EP0636173A1 (en) 1995-02-01
AU651228B2 (en) 1994-07-14
CA2108580A1 (en) 1992-12-01
EP0636173B1 (en) 1998-09-02
DE69226877D1 (de) 1998-10-08
WO1992021755A1 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
DK0636173T3 (da) Behandling af HIV associeret immunthrombocytopenisk purpura
DK442788A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
DK0814831T3 (da) Medikamenter til behandling af autoimmune sygdomme under anvendelse af interferon-tau
DE69331758D1 (de) Fibrinogen-bildungsprotein
GR82243B (da)
GB2255093A (en) Hiv-1 core protein fragments
DK241287D0 (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
DK422589A (da) Farmaceutisk praeparat til behandling af immundefekttilstande
DE68925660D1 (de) Peptidfragmente von HIV
DE69024105D1 (de) Verfahren zur Herstellung von gereinigten Albuminlösungen
ATE9437T1 (de) Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
FI941860A0 (fi) Keskushermoston pesäkekovettumatautiaivo-selkäydinnesteestä peräisin olevan antimyeliiniemäsproteiinin synteettinen peptidispesifisyys
DK0412766T3 (da) Peptidfragmenter af HIV
DK0994884T3 (da) Diphosphonsyresalte til behandling af osteoporose
DK0499541T3 (da) Fremgangsmåde til oprensning af et kraftigt glycosylerert protein
DK561589A (da) Flydende oralt farmaceutisk praeparat
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.